Clinical Trials Matching Software

Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the clinical trials matching software market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[185 Pages Report] The Clinical Trials Matching Software Market size was estimated at USD 342.20 million in 2023 and expected to reach USD 386.89 million in 2024, at a CAGR 13.54% to reach USD 832.56 million by 2030.

Clinical Trials Matching Software Market
To learn more about this report, request a free PDF copy

Clinical trials matching software are advanced platforms or systems designed to streamline the process of identifying and enrolling suitable participants into clinical trials. The clinical trials matching software aims to automate the identification of eligible study participants by matching their health data against trial criteria, thereby facilitating their enrollment. The technological advances in AI and ML algorithms have enabled more advanced patient-trial matching, propelling market growth. Government and regulatory bodies are increasingly supportive of using digital tools to enhance clinical trial processes, providing a conducive environment for market expansion. The shift toward personalized healthcare is driving need for clinical trials targeting specific patient populations, further bolstering the need for efficient matching software. However, disparate healthcare IT systems complicate the integration and consistent application of matching software across different platforms, limiting the market growth. Handling sensitive patient data requires stringent security measures, posing a significant challenge for market growth. Moreover, incorporating patient genomic information to enhance matching precision for trials focusing on genetic diseases and personalized medicine may create new growth avenues. The increasing emphasis on partnerships with hospitals and clinics to directly integrate trial matching within electronic health records (EHR) systems, generate significant growth potential in the market.

Clinical Trials Matching Software Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Functionality: Leveraging analytics, compliance, and patient matching for optimal efficiency and diversity

Analytics and reporting functionalities in clinical trial matching software provide comprehensive insights into trial progression, patient demographics, enrollment rates, and other crucial metrics. Analytics and reporting features enable stakeholders to make informed decisions by visualizing data trends and patterns. Analytics and reporting are paramount for optimizing trial efficiency and ensuring resource allocation aligns with trial objectives. Compliance tracking is critical for ensuring clinical trials adhere to regulatory requirements and standards. Compliance tracking helps manage documentation, track ethical approvals, and monitor adherence to trial protocols, significantly reducing the risk of non-compliance penalties.

Data management encompasses collecting, storing, and validating clinical trial data to ensure integrity and accessibility. Effective data management is essential for facilitating seamless data flow between trial sites and for enabling real-time data analysis. The preference for data management solutions varies depending on the scale of the trial and the complexity of data involved. Patient matching is at the core of clinical trial matching software, aimed at identifying and enrolling patients meeting the specific criteria for a given trial. Patient matching functionality leverages algorithms and artificial intelligence to sift through patient databases, speeding up the recruitment process and improving trial diversity.

End-Use: Diverse scope of applications in contract research organizations for seamless data flow

Contract research organizations (CROs) need efficient clinical trial matching software to streamline the process of identifying and enrolling suitable candidates for various studies. CROs prefer comprehensive, scalable solutions that can support multiple trials simultaneously with robust data security measures. Integration capabilities with other platforms for seamless data flow and real-time tracking features are highly valued in CROs. Medical device firms require tailored clinical trial matching software that accommodates unique criteria such as device classifications, target patient populations, and regulatory compliances. Medical device firms prioritize configurable software solutions that can adapt to the specific requirements of device trials, including multi-phase trial management and integration with device data management systems. The pharmaceuticals and biotechnology sector is the largest user of clinical trial matching software, driven by the need to accelerate drug development cycles and improve the accuracy of trial participant matching. Pharma and biotech companies demand highly secure, AI-powered platforms that offer advanced algorithms for precise matching, global regulatory compliance, and capabilities for handling complex data privacy requirements.

Deployment: Increasing cloud based deployment of clinical trials matching software for scalability

Cloud and web-based solutions for clinical trials matching software have been increasingly sought after due to their scalability, ease of access, and lower upfront costs. Cloud and web-based solutions allow healthcare providers and researchers to access the software from anywhere at any time, based on an Internet connection. On-premise solutions offer higher levels of control and security as the software and data are stored within the organization's own infrastructure. On-premise solutions are essential for organizations with susceptible patient data or strict compliance requirements.

Regional Insights

In the Americas region, particularly in the United States and Canada, the need for clinical trials matching software is driven by a robust clinical trials ecosystem, supported by significant investment in research and development. The North American region leads in the number of ongoing clinical trials, fueled by the presence of major pharmaceutical companies and a favorable regulatory environment. European Union countries exhibit a strong commitment to healthcare innovation, with considerable investments in clinical research. The EU's regulatory landscape, including the Clinical Trials Regulation (CTR), aims to streamline clinical trials across member states, raising the demand for cutting-edge matching software that can navigate diverse regulatory environments. The Middle East is substantially emerging as a hub for clinical trials, driven by government initiatives to diversify economies and improve healthcare outcomes. Africa presents a unique market with significant untapped potential for clinical trials matching software. In the APAC region, the strong focus on innovation and the adoption of technology in healthcare, including clinical trials matching software, cater to the vast patient population in China and India. Recent regulatory reforms in Japan aim to accelerate the approval process for clinical trials, boosting the need for effective matching software in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trials Matching Software Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trials Matching Software Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Trialbee and Massive Bio Forge Alliance to Advance Cancer Research Through Enhanced Clinical Trial Access

    Trialbee, a patient recruitment and enrollment solutions provider, announced a partnership with Massive Bio, known for its AI-driven patient journey mapping platform, enhancing clinical trial accessibility for cancer patients. This collaboration bridges the gap between cancer patients, their physicians, and clinical trials by leveraging Trialbee's omnichannel network and Massive Bio's extensive patient and provider outreach capabilities. [Published On: 2024-01-31]

  • Deep 6 AI and Graticule to Unveil AI-Driven Patient Matching for Faster, Efficient Recruitment

    Deep 6 AI, an AI-driven precision research platform, partnered with Graticule, a provider of advanced real-world data and advisory services for the development of research algorithms and real-world data services aimed at enhancing patient identification and prioritization for numerous clinical trials. This approach facilitates the rapid identification of eligible patients by extracting crucial insights from clinical narratives and streamlining the entire patient qualification process. As a result, research teams are equipped with a sophisticated tool that significantly accelerates trial completion while reducing the operational load on healthcare facilities. [Published On: 2024-01-05]

  • Medable and Pluto Health Forge Partnership to Enhance Patient Engagement in Clinical Trials

    Medable Inc. and Pluto Health collaborated to enhance patient involvement in clinical trials through technology integration. This partnership combined the strength of Medable's digital clinical trials platform with Pluto Health's health coordination services. The collaboration offers them the ability to seamlessly integrate and share their health data with clinical trials, improving patient support and care management. [Published On: 2023-10-04]

Key Company Profiles

The report delves into recent significant developments in the Clinical Trials Matching Software Market, highlighting leading vendors and their innovative profiles. These include Advarra, Inc., Antidote Technologies, Inc., AQ, Inc, AutoCruitment LLC, BBK Worldwide, LLC by Publicis Health company, BEKhealth Corporation, Belongtail Ltd., Carebox Healthcare Solutions, Inc., Clara Health by M&B Sciences Inc:, Clariness GmbH, Clario, ClinicalConnection, Inc., CSSi, Deep 6 AI Inc., Elligo Health Research, Inc., Evidation Health, Inc., Formation Bio, Inc., HCL Technologies Limited, HealthMatch Pty. Ltd., ICON plc, Inato, Inspirata, Inc., International Business Machines Corporation, IQVIA Holdings Inc., Lokavant, Inc., Medable Inc., Medidata by Dassault Systèmes SE, Medocity, Inc., Microsoft Corporation, Parexel International Corporation, PatientWing, Science 37, Inc. by eMed, LLC, Science4Tech Solutions, S.L., Sumatosoft LLC, Syneos Health, Inc., Teckro, Inc., Tempus Labs, Inc., Trialbee AB, TrialHub by FindMeCure Ltd., Veeva Systems Inc., and Worldwide Clinical Trials.

Market Segmentation & Coverage

This research report categorizes the Clinical Trials Matching Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Functionality
    • Analytics & Reporting
    • Compliance Tracking
    • Data Management
    • Patient Matching
  • Deployment
    • Cloud & Web Based
    • On-Premise
  • End-Use
    • CROs
    • Medical Device Firms
    • Pharmaceuticals & Biotechnology Companies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Clinical Trials Matching Software Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trials Matching Software Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Trials Matching Software Market?
  4. What is the market share of the leading vendors in the Clinical Trials Matching Software Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Trials Matching Software Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Clinical Trials Matching Software Market, by Functionality
  7. Clinical Trials Matching Software Market, by Deployment
  8. Clinical Trials Matching Software Market, by End-Use
  9. Americas Clinical Trials Matching Software Market
  10. Asia-Pacific Clinical Trials Matching Software Market
  11. Europe, Middle East & Africa Clinical Trials Matching Software Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 286]
  16. List of Companies Mentioned [Total: 41]
Frequently Asked Questions
  1. How big is the Clinical Trials Matching Software Market?
    Ans. The Global Clinical Trials Matching Software Market size was estimated at USD 342.20 million in 2023 and expected to reach USD 386.89 million in 2024.
  2. What is the Clinical Trials Matching Software Market growth?
    Ans. The Global Clinical Trials Matching Software Market to grow USD 832.56 million by 2030, at a CAGR of 13.54%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.